Primary amyloidosis (AL) as a cause of nephrotic syndrome.Bataille, Yoann ; Bovy, Christophe ; Lancellotti, Patrizio et alin Acta Clinica Belgica (2005), 60(2), 94-7 AL amyloidosis is a rare systemic disease resulting from tissue accumulation of amyloid fibrils derived from monoclonal immunoglobulin light chains. It can disrupt the tissue architecture and consequently ... [more ▼] AL amyloidosis is a rare systemic disease resulting from tissue accumulation of amyloid fibrils derived from monoclonal immunoglobulin light chains. It can disrupt the tissue architecture and consequently cause organ dysfunction. The prognosis is poor with a median survival of 13 months in untreated patients. By illustrating the case of a patient whose AL amyloidosis was detected after presenting a nephrotic syndrome, the characteristics of the disease are reviewed as well as diagnostic criteria and current available therapeutics. [less ▲] Detailed reference viewed: 52 (7 ULg) Mature erythrocyte indices: new markers of iron availability.Bovy, Christophe ; Gothot, André ; Krzesinski, Jean-Marie et alin Haematologica (2005), 90(4), 549-51 This study was aimed at evaluating mature erythrocyte indices as new markers of iron status. Contrarily to those in the whole red blood cell (RBC) population, mature erythrocyte parameters are valid ... [more ▼] This study was aimed at evaluating mature erythrocyte indices as new markers of iron status. Contrarily to those in the whole red blood cell (RBC) population, mature erythrocyte parameters are valid markers of iron status that remain independent of erythropoietic activity. When reticulocytosis is low, these parameters are similar to whole RBC parameters. [less ▲] Detailed reference viewed: 100 (4 ULg) Back pain and renal failureDelanaye, Pierre ; Bovy, Christophe ; de Leval, Laurence et alin Lancet (2004), 364(9449), 1992 Detailed reference viewed: 30 (13 ULg) Impact of erythropoietic activity on red cell parameters in chronic renal failure patients.Bovy, Christophe ; Krzesinski, Jean-Marie ; Gothot, André et alin Haematologica (2004), 89(6), 748-9 We measured red cell parameters during recombinant human erythropoietin (rHuEPO) therapy associated with appropriate iron supplementation in chronic hemodialysis patients. Increased erythropoietic ... [more ▼] We measured red cell parameters during recombinant human erythropoietin (rHuEPO) therapy associated with appropriate iron supplementation in chronic hemodialysis patients. Increased erythropoietic activity led to a bias in red cell parameter determination. The percentage of hypochromic red blood cells, usually used as the most effective predictor of response to iron supplementation, increased following the appearance of a younger red cell population since the same Hb content in these younger, larger cells gives a lower Hb concentration. [less ▲] Detailed reference viewed: 17 (6 ULg) Hypochromic mature erythrocytes: a specific marker of iron deficiencyBovy, Christophe ; Beguin, Yves ; Gothot, André et alin Acta Clinica Belgica (2003), 58-3(4), 325 Detailed reference viewed: 7 (2 ULg) Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise surveyBovy, Christophe ; Beguin, Yves ; Gothot, André et alin Acta Clinica Belgica (2003), 58-3(4), 328 Detailed reference viewed: 10 (1 ULg) Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and ageChapelle, Jean-Paul ; Dubois, Bernard ; Bovy, Christophe et alin Clinical Chemistry & Laboratory Medicine (2002), 40(3), 240-245 Detailed reference viewed: 5 (0 ULg) Markers of oxidative stress limited to increased risk of cardiovascular disease in chronic hemodialysis patientsPincemail, Joël ; Bovy, Christophe ; Chapelle, Jean-Paul et alin Free Radical Biology & Medicine (2001), 31(suppl), 345 Detailed reference viewed: 6 (1 ULg) Iron monitoring under vitamin C therapy in hemodialysed patients treated with erythropoietinBovy, Christophe ; Dubois, Bernard ; Weekers, Laurent et alin Nephrology Dialysis Transplantation (2000), 15(9), 156 Detailed reference viewed: 7 (1 ULg) Factors determining the percentage of hypochromic red blood cells in hemodialysis patients.Bovy, Christophe ; ; et alin Kidney International (1999), 56(3), 1113-9 Factors determining the percentage of hypochromic red blood cells determines iron status in hemodialysis patients. BACKGROUND: Determination of the percentage of hypochromic red blood cells (RBC; %HYPO ... [more ▼] Factors determining the percentage of hypochromic red blood cells determines iron status in hemodialysis patients. BACKGROUND: Determination of the percentage of hypochromic red blood cells (RBC; %HYPO) has been advocated as a sensitive index of functional iron deficiency during erythropoietin (EPO) therapy in hemodialyzed patients. METHODS: The significance of %HYPO in chronic renal failure was evaluated in 64 chronically hemodialyzed patients. The linear correlation was determined between %HYPO and 13 variables, including age, sex, weight, C-reactive protein (CRP), ferritin, transferrin (Tf), Tf saturation, soluble Tf receptor (sTfR), serum iron (SI), urea, parathormone, dialysis dose (Kt/V), dose of EPO administered (EPO), and absolute reticulocyte count. Multiple regression analyses were then performed to select the parameters that jointly provide the best prediction of %HYPO. RESULTS: Univariate analysis showed significant correlations between %HYPO and iron parameters (sTfR, Tf saturation, SI, and ferritin, in decreasing order), EPO, reticulocyte count, and CRP. Multivariate analysis yielded an equation showing that the variation of %HYPO is essentially associated with the combined changes in sTfR, CRP, and EPO dosage. CONCLUSIONS: %HYPO is a meaningful and inexpensive parameter that reflects the integrated effects of iron stores, inflammation, and erythropoietic stimulation on iron availability in hemodialyzed patients. Among iron exchange parameters, sTfR is the best predictor of %HYPO, followed by Tf saturation, SI, and ferritin. [less ▲] Detailed reference viewed: 47 (2 ULg) Lipids, risk factor in hemodialysed patients?BOVY, Christophe ; Saint-Remy, Annie ; et alin Nephrology Dialysis Transplantation (1998), 13 Detailed reference viewed: 5 (2 ULg) Intravenous or subcutaneous administration of erythropoietin (rHu-EPO)- what to choose?BOVY, Christophe ; Saint-Remy, Annie ; Rorive, Georges ![]() in Nephrology Dialysis Transplantation (1997) Detailed reference viewed: 10 (0 ULg) Mode of administration of Erythropoetin (rHu-Epo)- Does it matter?BOVY, Christophe ; DUBOIS, Bernard ; et alin Nephrology Dialysis Transplantation (1995), 10 Detailed reference viewed: 13 (0 ULg) |
||